C07C 233 - Carboxylic acid amides

Patents for C07C 233 - Carboxylic acid amides (28,881)
11/2006
11/22/2006	CN1285567C Process for synthesizing paracetamol
11/21/2006	US7138547 Antitumoral compounds
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	CA2158060C Process for the preparation of .beta.-phenylisoserine derivatives
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/21/2006	CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof
11/16/2006	WO2006122259A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
11/16/2006	WO2006122054A1 Diamondoid derivatives possessing therapeutic activity
11/16/2006	WO2006121150A1 (meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and method for forming pattern
11/16/2006	WO2006083924A8 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
11/16/2006	WO2006067103A3 Process for the preparation of a 2-pyridylethylcarboxamide derivative
11/16/2006	US20060258866 Carboxylic derivates
11/16/2006	US20060258748 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
11/16/2006	CA2608248A1 Soluble epoxide hydrolase inhibitors and methods of using same
11/16/2006	CA2607241A1 Diamondoid derivatives possessing therapeutic activity
11/16/2006	CA2607198A1 Dihydroxyphenylalanine derivatives
11/16/2006	CA2604624A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
11/15/2006	EP1720826A2 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
11/15/2006	EP1720825A1 New compounds, methods for their preparation and use thereof
11/15/2006	EP1720823A1 New process for the synthesis of substituted alpha-aminoidan derivatives
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	CN1863842A Aspartate derivatives and process for their preparation
11/15/2006	CN1861577A Tech. of preparing 2-amino-4-acetamido methyl-phenoxide
11/15/2006	CN1861562A Process of producing nitrobenzether aminobenzether amidobenzether from chlorobenzene
11/15/2006	CN1284772C Benzamide kind histon deacetylase inhibiting agent having dissociation and antibred activity and its medicinal preparation
11/14/2006	US7135598 N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof
11/14/2006	US7135586 Biphenylcarboxamides useful as lipid lowering agents
11/14/2006	US7135585 Pyrrole derivatives, for controlling plant diseases caused by fungal plant pathogens
11/14/2006	US7135502 Colchinol derivatives as vascular damaging agents
11/14/2006	US7135493 HDAC inhibitor
11/09/2006	WO2006118955A2 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/09/2006	WO2006118155A1 Biphenyl derivative or salt thereof, and bactericide for agricultural and horticultural use containing same as active ingredient
11/09/2006	WO2006117602A2 Use of amide derivatives as taste-modifying agents, flavouring compositions and products containing them
11/09/2006	WO2006025978A3 Non-antibiotic intervention of chlamydial infection
11/09/2006	US20060252832 Derivatives of acanthoic and kauranoic acid; treatment of cachexia' cardiovascular disease, otitis media, sinusitis and transplant; anti-inflammatory, diabetic and cancer agents
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	CA2603818A1 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
11/08/2006	EP1718602A1 Therapeutic and carrier molecules
11/08/2006	EP1718582A2 Method for selective reduction of aromatic compounds
11/08/2006	EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006	EP1324979B1 Ionic liquids and their use as solvents
11/08/2006	CN1283612C Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/08/2006	CN1283148C Use of compsn. having insect repellent characteristics
11/07/2006	US7132570 Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
11/07/2006	US7132569 N,N-disubstituted-2,7-dialkyl-8-aryl-4-octeneamides and the intermediates: N,N-disubstituted-5-halo- or azido-2-alkyl-4-pentenamides and 2-alkyl-5-(4-aryl-2-halo- or azido-3-alkylbutylbutyrolactones that may be used to prepare them
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132567 Composition for use in the adhesion of particle to surfaces
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132455 Phthalamide derivatives
11/02/2006	WO2006116485A2 Trpv1 agonist compounds and methods for making and using the same
11/02/2006	WO2006114262A1 Acetylene derivatives
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	WO2006061215A3 2-alkyl-cycloalk(en)yl-carboxamides
11/02/2006	US20060247324 Paper products softening compositions
11/02/2006	US20060247296 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
11/02/2006	US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006	US20060247239 Melanin concentrating hormone antagonists
11/02/2006	US20060246482 Linker molecules for selective metallisation of nucleic acids and their uses
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716116A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
11/02/2006	EP1716099A1 Haloalkylcarboxamides for combatting microorganisms
11/02/2006	EP1716098A1 Processes for preparing n-acetylcolchinol & intermediates used in such processes
11/02/2006	EP1716097A2 New process for the synthesis of eneamide derivatives
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1339685B1 Biphenylcarboxamides useful as lipid lowering agents
11/02/2006	EP1301458A4 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	CA2606086A1 Trpv1 agonist compounds and methods for making and using the same
11/02/2006	CA2605265A1 Acetylene derivatives
11/01/2006	CN1856565A Detergent compositions and processes for the production thereof
11/01/2006	CN1856465A Amino-substituted ethylamino beta2 adrenergic receptor agonists
11/01/2006	CN1856464A 氨基链烷醇衍生物 Amino alkanol derivative
11/01/2006	CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006	CN1854118A Indane acetic acid compound
11/01/2006	CN1853619A Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
10/2006
10/31/2006	US7129377 Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/26/2006	WO2006111771A2 Object, apparatus and process for removing, destroying or reducing the growth of organic material
10/26/2006	WO2006111653A1 Use of agomelatine for obtaining medicaments used for treating bipolar disorders
10/26/2006	WO2005112633A3 Compounds and compositions for delivering active agents
10/26/2006	WO2003006628A3 Nad synthetase inhibitors and uses thereof
10/26/2006	US20060241307 Ligands for asymmetric reactions
10/26/2006	US20060241179 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
10/26/2006	US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
10/26/2006	US20060241071 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids
10/26/2006	US20060240127 Use of agomelatine in obtaining medicaments intended for the treatment of bipolar disorders
10/26/2006	DE10126572B4 Polyhydroxyamide und daraus erhältliche hochvernetzte chemisch und thermisch stabile Polymere Polyhydroxyamides and obtainable therefrom highly crosslinked chemically and thermally stable polymers
10/25/2006	EP1714962A1 Dehydrating condensation agent having property of accumulating at interface with water
10/25/2006	EP1714647A1 Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
10/25/2006	EP1713465A2 Compounds and compositions as lxr modulators
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1157006B1 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
10/25/2006	CN1852901A Organic compounds
10/25/2006	CN1281602C Novel carboxylate herbicides
10/25/2006	CN1281582C High-optical-purity chiral beta-alkamine compound, preparing method and its use
10/24/2006	US7126027 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
10/24/2006	US7126026 For treatment of cardiovascular disorders; high yield; reducing, halogenating, hydrolyzing a 4-nitrophenylsulfur pentafluoride

1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 289